Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (52)
  • 2024 (35)
  • 2023 (73)
  • 2022 (150)
  • 2021 (134)
  • 2020 (26)
  • 2019 (6)
  • 2018 (2)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Diversion Division (253)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Major Law Enforcement Operation (275)
  • Pharmaceuticals/Pharmacists/Physicians (227)

Drug Name

  • Fentanyl (149)
  • Cocaine (115)
  • Methamphetamine (86)
  • Heroin (76)
  • Opioids (53)
  • Oxycodone (51)
  • Synthetic Opioids (27)
  • Marijuana (Cannabis) (20)
  • Hydromorphone (15)
  • Morphine (8)
  • Benzodiazepines (7)
  • Ecstasy/MDMA (4)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • GHB (1)
  • K2/Spice (1)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • Washington, DC (150)
  • St. Louis (48)
  • New York (39)
  • El Paso (33)
  • Chicago (23)
  • Miami (22)
  • New Jersey (20)
  • Sede (20)
  • San Francisco (18)
  • Seattle (16)
  • Atlanta (14)
  • Dallas (13)
  • Houston (13)
  • San Diego (12)
  • New England (9)
  • New Orleans (8)
  • Los Angeles (7)
  • Rocky Mountain (7)
  • Louisville (6)
  • Phoenix (5)
  • Omaha (3)
  • Philadelphia (1)
Clear All Results
487 Results - Showing 441 to 450
PRESS RELEASE

DEA Launches Project Wave Breaker to Stop Flood of Deadly Fentanyl

HOUSTON – Today the Drug Enforcement Administration announced a new initiative, Project Wave Breaker, to disrupt the flow of deadly fentanyl into the United States. Project Wave Breaker will direct interdiction, enforcement, and outreach efforts to the DEA Houston Division to disrupt the flow of fentanyl in and around the...
PRESS RELEASE

DEA Launches Project Wave Breaker to Stop Flood of Deadly Fentanyl

EL PASO – Today the Drug Enforcement Administration announced a new initiative, Project Wave Breaker, to disrupt the flow of deadly fentanyl into the United States. Project Wave Breaker will direct interdiction, enforcement, and outreach efforts to the El Paso Division to disrupt the flow of fentanyl in and around...
PRESS RELEASE

Newport News Trafficker Pleads Guilty to Receiving Over 200 Kilograms of Cocaine

NEWPORT NEWS, Va. – A Newport News man pleaded guilty today to conspiring with members of an international drug trafficking organization to possess and distribute more than 200 kilograms of cocaine. According to court documents, Darrell King, II, 45, was a kilogram dealer of cocaine in the Tidewater area. Between...
PRESS RELEASE

Manager in Major Baltimore Drug Trafficking Organization Sentenced

Baltimore, MD – U.S. District Judge Paul W. Grimm sentenced Desmond Ringgold, a/k/a Worm and Fool, age 32, of Baltimore, Maryland to 15 years in federal prison, followed by five years of supervised release, for his role as a supervisor in a prolific drug trafficking organization (DTO) that operated in...
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
PRESS RELEASE

Operation Frontier Justice - Topeka Results in 258 Arrests

TOPEKA, Kans. – For 10 days in March, the U.S. Marshals and Topeka Police, working with multiple federal, state and local law enforcement partners, conducted an operation designed to reduce violent crime and drug activity in and around Topeka, resulting in 258 arrests. Operation Frontier Justice was conducted in partnership...
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...

Paginación

  • Primera página «
  • Anterior
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Current page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster